Professional Documents
Culture Documents
Medical disasters
Since the first major Drug- related disaster involving the elixir of Sulfanilamide in 1937, which killed 107 children, there have been several cases of severe adverse reactions and even deaths, eg., Thalidomide in 1961, Practolol in 1974, Benoxaprofen and Phenformin in 1982 and several others, leading to withdrawals and banning of these drugs. Since 1993 , seven other drugs were withdrawn from the market due to fatalities and unacceptable side-effects.
D I A B E T E S
History of Diabetes
Charaka and Sushruta described the disease under the name of 'Prameha' aptly 3000 years B.C. The references to disorders with polyuria are found in Egyptian papyrus (1500 B.C.). The Chinese physicians, Neijing (400 B.C.) and Celsus (30 B.C. 50A.D) of Greece have described the important symptoms of the disease.
Aretaeus named the disease as 'Diabetes' in second century A.D., as he perceived that the condition was characterized by "Melting down of flesh and limbs into urine."
Descriptions of the islet cells of 'Langerhans' (1869), production of Diabetes by pancreatectomy by Van Mering and Minkowski (1889) and detection of islet cells lesion in Diabetes in 1901 were followed by successful extraction of insulin by Banting and Best (1921). (Extraction From Bovine Pancreas)
Oral hypoglycemic drugs invented by Frank and Fuchs (1955) simplified the management of NIDDM
PREVENTING DIABETES
FACTS
DIABETES IS SPREADING LIKE AN EPEDEMIC DIABETES SPARES NO ORGAN CARE TODAY WILL HELP US TOMORROW
RISK FACTORS
Positive family history of diabetes Age of 35 years. Over weight, and have gained weight recently. Sedentary life style and lack of exercise Bad obstetric history
195%increase by 2025.
Types of Diabetes
1. Type I Diabetes Mellitus(Insulin Dependant DM)
Etiological Factors
Apathyakar Aahar (Dietary factors)
CURD, MEATS, MILK & ITS PRODUCTS NEW GRAINS, PRODUCTS OF JAGGERY
Excessive growth of nails and hairs. Sweet taste in the mouth. Dryness of palate and throat. Thirst . Attraction towards cold objects. Presence of excessive Malas all over the body.
Honey like urine. Greasiness and numbness over body. Excessive sleep. Fatigue. apathy. lack of pleasure etc. Attraction of Ants over the urine.
Pathogenesis of Prameha
Dosha(Humors):Tridoshas i.e., Vata, Pitta, Kapha
( Kaphapredominant )
Pathophysiology of Prameha
NIDAN SEVAN
DOSHA PROPAK & DATHU SAITHALAYA BAHU DRAVATA OF KAPHA DEHA SANCHAR MIXES WITH VITIATED MEDA, KLEDA DRAVA DATHUS CONVERT TO MUTRA KSHARAN VIA MUTRAVAHA STROTASA DHATUKSHAYA MADHUMEHA
PRAMEHA
Classification of Prameha
ACCORDING TO DOSHA- Vataja-4, Pittaja-6,Kaphaja-10.
ACCORDING TO ETIOLOGY
- Dietary, Congenital, Familial
ACCORDING TO MANAGEMENT
- Obese (Sthula), Lean (Krisha)
ACCORDING TO PROGNOSIS
- Sadhya. Asadhya, & Yapya
Madhumeha TYPES: 2
1. Lean Diabetics from the beginning 2. Obese to begin, but later become lean
Prognosis of Prameha/Madhumeha
Kaphaja(Obese)- Curable, Pittaja(Medium)- Palliative, Vataja(Lean)-Incurable Hereditary & Familial Incurable Extreme weightless(Kaphaj Pittaja Vataja Madhumeha): INCURABLE Involvement of fatty tissue, muscles, lymphatics, nerves, & blood vessels
Excessive thirst Diarrhea Burning sensations all over body Extreme weakness Indigestion Loss of appetite Foul smelling abscesses/ulcerations
Prameha Upadravas
Vataja Prameha
Pittaja Prameha
Kaphaja Prameha
Prof. Kohli
PROGNOSIS OF PRAMEHA/MADHUMEHA Kaphaja(Obese)- Curable, Pittaja(Medium)- Palliative, Vataja(Lean)-Incurable Hereditary & Familial Incurable Extreme weightloss(Kaphaj Pittaja Vataja Madhumeha): INCURABLE Involvement of fatty tissue, muscles, lymphatics, nerves, & blood vessels
Line of treatment
1) Snehanam External & Internal 2) Shodhanam
Vamanam Virechanam Basti
GYMNEMA SYLVESTRE
Gymnema
Researches show that Gymnema lowers the blood glucose by following mechanisms It appears to correct the metabolic derangements in diabetic rabbit liver, kidney and muscle. This herbal therapy appears to bring about blood glucose homeostasis through increased serum insulin levels provided by repair/regeneration of the endocrine pancreas. Gymnema therapy appears to enhance endogenous insulin, possibly by regeneration/revitalisation of the residual beta cells in insulin-dependent diabetes mellitus.. studies suggest that the component of Gymnema sylvestre inhibits the increase in the blood glucose level by interfering with the intestinal glucose absorption process
Gymnema
Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability. Persaud SJ, Al-Majed H, Raman A, Jones PM. Suppression of glucose absorption by extracts from the leaves of Gymnema inodorum. Shimizu K, Ozeki M, Tanaka K, Itoh K, Nakajyo S, Urakawa N, Atsuchi M. Beta cells may be regenerated/repaired in Type 2 diabetic patients on GS4 supplementation. This is supported by the appearance of raised insulin levels in the serum of patients after GS4 supplementation. J Ethnopharmacol 1990 Oct;30(3):295-300 Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, Shanmugasundaram ER.
An active constituent of Pterocarpus marsupium, (-)-epicatechin (1) in,low doses, has been reported to reverse hyperglycemia in alloxan diabetic rats when given before or within 24 hr after the dose of alloxan. The antihyperglycemic activity of ethanolic extract of Vijaysara bark at the dose of 0.25 g/kg b.w. was found to be more effective than that of glibenclamide and metformin. Vijayasar is useful in the treatment of newly diagnosed or untreated mild NIDDM patients Indian J Med Res 1998 Jul;108:24-9
VIJAYSAR
Jamun Beej
Prof. Kohli
5 4
3 2
1 0 INITIAL AFTER 4 WKS. GRADE 1 AFTER 8 WKS. AFTER 12 WKS. GRADE 2 GRADE 3
GRADE 0
Prof. Kohli
GRADE 0
Prof. Kohli
GRADE 0
Prof. Kohli
2 1.8
GRADE SCORES
1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 0 INITIAL AFTER 4WKS. AFTER 8WKS. AFTER 12 WKS.
Prof. Kohli
B L O O D S U G A R
200
INITIAL 4 WKS
150
8 WKS 12 WKS
100
I N
M G M %
50
0
INITIAL 4 WKS 8 WKS FBS(EJP) 12 WKS FBS(GSP)
FBS(PMP)
Prof. Kohli
B L O O D
4 WKS
8 WKS 12 WKS
S U G A R
100 50 0
PPBS(PMP) PPBS(EJP) PPBS(GSP)
FICUS BENGALENSIS
Prof. Kohli
350
B L 300 O O D
250
S U 200 G A R
I N
150
M 100 G M % 50
KARELA
Diabetes Res Clin Pract 2001 Mar;51(3):155-61 Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Ahmed I, Lakhani MS, Gillett M, John A, Raza H. These results suggest that M. charantia fruit extract exhibits hypolipidemic as well as hypoglycemic effects in the STZ-induced diabetic rat.
KARELA
Bangladesh Med Res Counc Bull 1999 Apr;25(1):11-3
Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. Ahmad N, Hassan MR, Halder H, Bennoor KS.
Department of Pathology, Sher-e-Bangla Medical College, Barisal.
This hypoglycaemic action was observed in 86 (86%) cases The results indicated that there was a significant (Student's t-test, P < 0.004) increase in the number of beta cells in M. charantiatreated animals when compared with untreated diabetics, however, their number was still significantly less than that obtained for normal rats.
Karela is the well-known plant as an anti-diabetic. Its mode of action is studied intensively in last several years. It shows Orally administered karela extracts shows lower glucose concentrations independently of intestinal glucose absorption and involve an extrapancreatic effect. Momordica charantia extract lowered blood glucose by depressing its synthesis, on the one hand through depression of the key gluconeogenic enzymes glucose-6phosphatase and fructose-1, 6-bisphosphatase and on the other by enhancing glucose oxidation by the shunt pathway through activation of its principal enzyme G6PDH. The mechanism of action of M. charantia could be partly attributed to increased glucose utilization in the liver rather than an insulin secretion effect. Oral feeding of M. charantia fruit juice may have a role in the renewal of beta cells in STZ-diabetic rats or alternately may permit the recovery of partially destroyed beta cells.
KARELA
SHILAJEET
Prof. Kohli
350
B L O O D
300
INITIAL 4 WKS
250
8 WKS
S U G A R
200
INITIAL 4 WKS 8 WKS
150
I N
M G M %
100
50
METHI
Effect of Trigonella foenum graecum (Fenugreek) on blood glucose in normal and diabetic rats. Khosla P, Gupta DD, Nagpal RK. Department of Pharmacology, Pt. B. D. Sharma Medical College, Rohtak. Trigonella foenum graecum (Fenugreek) was administered at 2 and 8 g/kg dose orally to normal and alloxan induced diabetic rats. It produced a significant fall (P < 0.05) in blood glucose both in the normal as well as diabetic rats and the hypoglycemic effect was dose related.
METHI
Hypoglycaemic and antihyperglycaemic effects of Trigonella foenum-graecum leaf in normal and alloxan induced diabetic rats. Abdel-Barry JA, Abdel-Hassan IA, Al-Hakiem MH.
Department of Chemistry, College of Science, University of Basrah, Iraq.
Prof. Kohli
Prof. Kohli
Prof. Kohli
SENSORY NEUROPATHY
Study Center: M. A. Podar Hospital and Drishti Eye and Retina Center, Opera House, Mumbai.
Dose: Two tablets each of Weighing 500mg twice daily on empty stomach.
Duration of Treatment: 3 months Diet: whatever advised for effective control of Diabetes was prescribed.
Inclusion Criteria
Established cases of Diabetic retinopathy were
selected.
Patients of both sexes and age between 25 to 70
selected in the trial was maintained through out the period of trial.
Exclusion Criteria
Patients having retinal detachment and retinal injury requiring immediate medical and /or surgical intervention were not included in the study. Patients with history of previous surgery for ophthalmic cause were excluded. Patients with renal failure, Pulmonary tuberculosis, liver disorders, Pregnancy and lactation were not included in the trial.
of
retinopathy
Assessment of Patients
CBC, Hb % and ESR, Urine examination BUN, BUL, Serum Creatinine and Glycosylated Hb% was done at the starting and at the
fundus photographs and vision test for Diabetic retinopathy was performed at entry and at the end of study.
Fundoscopy with dilated pupils Dilatation of Pupils with Tropicamide solution 2% Slit Lamp Examination Fundus Photography
Selection of Drug
Drug should have capacity to check Bahudravata,
Properties.
Drug should be Chakshushya i.e. beneficial for eyes. It should have properties to correct Dhatukshaitilya
and Dhatuksharan
And above all drug should have Rasayana property.
Nishadiyoga
Haridra Amalaki Haritaki Vibhitak
Equal parts of extracts of each ingredients were taken and a tablet each of weighing 500 mg is made. M/s Zandu Pharmaceutical Ltd helped in preparation of Tablets.
Contents of Nishadiyoga
Curcuma longa
Ficus bengalensis
Terminalia belerica
Terminalia chebula
Phyllanthus embelica
Asparagus racemosus
Cyperus rotundus
Glycerrhiza glabbra
Properties of Nishadiyoga
Pramehaghna
Rasayana
Chakshushya
Pramehaghna
Majority of the contents of the drugs have
been used in many classical formulations, which are in use since long to treat Prameha Vyadhi and its Upadravas i. e. complications. Drugs like Nyagrodha, Haridra, Triphala and Mustha have proven anti-diabetic activity.
Chakshushya
The literary meaning of this word is the substance, which has wholesome action towards improving the eyesight.
The drugs with this action possess capacity to reach upto minute senses. Thus they are very potent drug and have specific site of action as Chakshu i. e. eye. Drugs like Haridra, Shatavari, Amalki, Yashtimadhu, Haritaki and Bibhitak have strong Chakshushya action.
Rasayana
Providing adequate and proper nutritious food / material to the body. Proper functioning of the Srotas where Dhatu is produced.
Proper functioning of Vata, which is responsible for the transportation of processed material
Proper functioning of the digestive power at all levels i.e. Jatharagni, Dhatavagni and Bhutagni. Proper functioning of all Indriyas.
Results
18 16 14 12 10 8 6
10
17
4 2 0
Improvement Same Worsen
PATIENT NO. 1
BEFORE TREATMENT AFTER TREATMENT
Moderate to severe NPD Moderate to severe NPDR Reduced exudates and Hemorrhages, Better Improvement
PATIENT NO. 2
BEFORE TREATMENT AFTER TREATMENT
PATIENT NO. 3
BEFORE TREATMENT AFTER TREATMENT
PATIENT NO.4
BEFORE TREATMENT AFTER TREATMENT
BDR
PATIENT NO. 5
BEFORE TREATMENT AFTER TREATMENT
PATIENTS NO. 6
BEFORE TREATMENT AFTER TREATMENT
Conclusion
This study strongly suggests that there is a (33.33%) chance of improvement in the condition of retina after 12 weeks of treatment with Nishadiyoga Ghanvati. Considering the available management in day to day practice, this management is relatively safe, easily available with greater extent of chance of recovery.
The cure of Prameha patients should be understood from the non-slimy and unturbid condition of the urine and from its clear transparent aspect and bitter or pungent taste.